アラビドプシスのCRISPR-Cas媒介遺伝性染色体融合
Michelle Rönspies1, Solmaz Khosravi2, Ondřej Helia3,4
1Joseph Gottlieb Kölreuter Institute for Plant Sciences - Molecular Biology, Karlsruhe Institute of Technology, Karlsruhe, Germany.
まとめ
科学者はCRISPR-Cas9遺伝子編集を用いて アラビドプシス・タリアナの染色体数を減少させ,染色体構造が変化した肥沃な植物を生み出した. これらの変化は子孫の生育能力と再結合に影響を及ぼし,新しい植物育種戦略の可能性を示唆した.
科学分野:
- 植物遺伝学
- ゲノム工学
- 分子生物学
背景:
- アラビドプシス・タリアナは 10個の染色体を持つゲノムを持っています
- 染色体の構造と機能を理解することは 植物育種に不可欠です
- CRISPR-Cas9技術は 精密なゲノム編集を可能にします
研究 の 目的:
- アラビドプシス・タリアナの染色体数減少の影響を調査する.
- 植物育種のための指向性染色体融合の可能性を調査する.
- 植物のゲノムを設計されたカリオタイプ変化に耐えるかを評価する.
主な方法:
- 特定のゲノム部位 (サブセントロメリックとサブテロメリック配列) でCRISPR-Cas媒介の断裂を誘導する.
- アラビドプシス・タリアナの2つの8染色体を 染色体腕融合で生成する.
- 表現型と転写分析を行う.
- 野生の植物と交配し,子孫を分析する.
主要な成果:
- 2つの肥沃な8染色体のアラビドプシス・タリアナ系が成功しました
- 遺伝子組み換え植物と野生型の植物の間では,フェノタイプや転写の違いは見られませんでした.
- 野生の植物と交配した子孫は 肥沃性が低下した.
- 移植された染色体の再結合パターンは有意に変化した.
結論:
- 植物では誘導性染色体数減少が可能である.
- 工学的なカリオタイプの変化は 植物ゲノムの強度を示しています
- 染色体構造の変化は 肥沃性やミオスの再結合に 影響を及ぼします
- このアプローチは 植物育種と遺伝子操作に 新たな道を開くかもしれません
関連する概念動画
Homologous Recombination
62.5K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
62.5K
CRISPR/Cas9 Genome Editing
1.6K
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
1.6K
CRISPR
57.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
57.4K
CRISPR and crRNAs
18.7K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
18.7K
Transgenic Plants
8.4K
Recombinant DNA technology called transgenesis is often used to add a foreign gene or remove a detrimental gene from an organism. Such genetically modified organisms are called transgenic organisms.
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
The first-ever transgenic plant was a tobacco plant developed in 1983 that showed resistance against the tobacco mosaic virus. Since then, many transgenic plants have been developed and commercialized for improving the agricultural, ornamental, and horticultural value of a crop plant. Transgenic...
8.4K


